Boehringer Ingelheim, a leading provider of animal health products for poultry, pets and livestock, marked the completion of work on October 9 on the expansion of its site in Athens, Georgia.
The investment, valued at $76 million, doubled the company's capacity to produce vaccines for pets in the United States and around the world.
Read full story at WattAgNet.com
